Regeneron Pharmaceuticals shares owned by Vantage Consulting Group
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Vantage Consulting Group
from 13F filings
Historical chart of Vantage Consulting Group investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Vantage Consulting Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Vantage Consulting Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $243k | 277 | 878.29 |
| 2023-09-30 | $232k | 282 | 822.96 |
| 2023-06-30 | $221k | 307 | 718.54 |
| 2023-03-31 | $263k | 320 | 821.67 |
| 2022-12-31 | $231k | 320 | 721.49 |
| 2022-09-30 | $247k | 359 | 688.02 |
| 2022-06-30 | $251k | 425 | 590.59 |
| 2022-03-31 | $251k | 359 | 699.16 |
| 2021-12-31 | $246k | 390 | 630.77 |
| 2021-09-30 | $227k | 375 | 605.33 |
| 2021-06-30 | $237k | 424 | 558.96 |
| 2020-12-31 | $74k | 153 | 483.66 |